Publications and communications of Etienne BAUDOUX

Articles in scientific journals with peer reviewing

C. GREGOIRE* , N. LAYIOS* , B. LAMBERMONT, C. LECHANTEUR, A. BRIQUET, V. Bettonville, E. BAUDOUX et al. "Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial." Frontiers in Immunology, 13 (04 July 2022): 932360. doi:10.3389/fimmu.2022.932360
* These authors have contributed equally to this work.

E. Forcade, S. Bacquet, C. Ballot, L. Capin, F. GARNIER, C. Giraud, M.-A. Guérout-Vérité et al. "Modalités et impact de la cryopréservation des greffons allogéniques en contexte pandémique : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)." Bulletin du Cancer (2022). doi:10.1016/j.bulcan.2022.03.015

S. VIEUJEAN, J.-P. LOLY, L. BOUTAFFALA, P. MEUNIER, C. REENAERS, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, Y. BEGUIN, and E. LOUIS. "Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study." Journal of Crohn's and Colitis, 16 (2022): 506-510. doi:10.1093/ecco-jcc/jjab154

J. Ingels, S. De Smet, K. Heyns, N. Lootens, J. Segaert, T. Taghon, G. Leclercq et al. "Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells." Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, 76 (2021): 482-486. doi:10.1080/17843286.2020.1752446

M. Jöris, K. Paulson, L. Foley, M. Duffy, S. Querol, S. Gomez, and E. BAUDOUX. "Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow DonorAssociation Cord Blood Working Group." Stem Cells Translational Medicine, 10 (2021): 222-229. doi:10.1002/sctm.20-0246

C. LECHANTEUR, A. BRIQUET, V. Bettonville, E. BAUDOUX, and Y. BEGUIN. "MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process." Cells, 10 (2021): 1320. doi:10.3390/cells10061320

B. Calmels, E. Gautier, A. Magnani, E. Magrin, A. C. Mamez, A. Vaissié, I. Yakoub-Agha, and E. BAUDOUX. "Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." Bulletin du Cancer (2020). doi:10.1016/j.bulcan.2020.06.005

J.-H. Dalle, E. BAUDOUX, S. Caillat-Zucman, F. Colledani, M. PEREIRA-MARTINS, B. Bruno, S. Nguyen, M. Robin, and M. T. Rubio. "Le développement des cellules CAR-T et autre thérapie génique : tout n’est pas si simple." Bulletin du Cancer, 107, no. 4 (April 2020): 408-409. doi:10.1016/j.bulcan.2020.03.002

J.-P. HAUZEUR, C. LECHANTEUR, E. BAUDOUX, V. De Maertelaer, S. Pather, R. Katz, M. Malaise, J. Ino, and Y. Beguin. "Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial." Clinical Orthopaedics and Related Research, 478 (2020): 1307-1315.

J. De Vos, E. BAUDOUX, J.-O. Bay, B. Calmels, A. Cras, J. El Cheikh, M.-A. Guerout-Verite et al. "Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." Bulletin du Cancer, 106 (December 2019): 35-S39. doi:10.1016/j.bulcan.2018.10.002

P. ERPICUM, L. WEEKERS, O. DETRY, C. BONVOISIN, M.-H. DELBOUILLE, C. GREGOIRE, E. BAUDOUX et al. "Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study." Kidney International, 95 (2019): 693-707. doi:10.1016/j.kint.2018.08.046

Y. de Jamblinne, E. BAUDOUX, C. Delo, and Y. Coppieters. "Influence de facteurs obstétricaux sur les caractéristiques des greffons de sang de cordon ombilical." Gynécologie Obstétrique et Fertilité, 46 (August 2018): 639-644. doi:10.1016/j.gofs.2018.07.005

J.-P. HAUZEUR, V. De Maertelaer, E. BAUDOUX, M. MALAISE, Y. Beguin, and V. Gangji. "Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial." International Orthopaedics, 42 (2018): 1429-1435. doi:10.1007/s00264-017-3650-8

S. Servais, F. Baron, C. LECHANTEUR, L. SEIDEL, D. Selleslag, J. Maertens, E. BAUDOUX et al. "Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study." Oncotarget, 9, no. 29 (2018): 20590-20604. doi:10.18632/oncotarget.25020

O. DETRY, M. VANDERMEULEN, M.-H. DELBOUILLE, J. SOMJA, N. BLETARD, A. Briquet, C. LECHANTEUR et al. "Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study." Journal of Hepatology, 67, no. 1 (July 2017): 47-55. doi:10.1016/j.jhep.2017.03.001

C. GREGOIRE, C. LECHANTEUR, A. BRIQUET, E. BAUDOUX, F. BARON, E. LOUIS, and Y. BEGUIN. "Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases." Alimentary Pharmacology and Therapeutics, 45 (2017): 205-221. doi:10.1111/apt.13864

O. Nikolajeva, V. Rocha, R. Danby, A. Ruggeri, F. Volt, E. BAUDOUX, S. G. Gomez et al. "Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia." Biology of Blood and Marrow Transplantation (2017). doi:10.1016/j.bbmt.2017.06.022

F. Boulanger, V. Decot, G. Bulliard, B. Calmels, C. Giraud, M. N. Lacassagne, A. Magnani et al. "Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient: recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)." Bulletin du Cancer (2016). doi:10.1016/j.bulcan.2016.09.002

R. Saccardi, L. Tucunduva, A. Ruggeri, I. Ionescu, G. Koegler, S. Querol, G. Grazzini et al. "Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis." Transfusion, 56, no. 8 (31 May 2016): 2021-2029. doi:10.1111/trf.13661

C. LECHANTEUR, A. BRIQUET, O. GIET, O. DELLOYE, E. BAUDOUX, and Y. BEGUIN. "Clinical - scale expansion of mesenchymal stromal cells: a large banking experience." Journal of Translational Medicine, 14 (2016): 145-159. doi:10.1186/s12967-016-0892-y

S. SERVAIS, C. GREGOIRE, F. BARON, E. WILLEMS, A. BRIQUET, E. BAUDOUX, O. DELLOYE, O. GIET, C. LECHANTEUR, and Y. BEGUIN. "Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation." Belgian Journal of Hematology, 7 (2016): 229-235.

H. Rouard, F. Boulanger, E. BAUDOUX, B. Calmels, J. de Vos, E. Gautier, M. N. Lacassagne et al. "Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC." Hématologie, 21, Supp 3 (December 2015): 42-46. doi:10.1684/hma.2015.1070

J. P. Pirnay, E. BAUDOUX, O. Cornu, A. Delforge, C. Delloye, J. Guns, E. Heinen et al. "Access to human tissues for research and product development." EMBO Reports, 16, no. 5 (07 April 2015): 1-6. doi:10.15252/embr.201540070

M. Binsfeld, M. HANNON, E. Otjacques, S. Humblet-Baron, E. BAUDOUX, Y. BEGUIN, F. BARON, and J. CAERS. "Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation." Cancer Immunology, Immunotherapy, 64 (2015): 989-998. doi:10.1007/s00262-015-1708-2

R. Saccardi, C. Azqueta, C. Ballerini, L. Ballerini, E. BAUDOUX, R. Caporale, S. Dal Pozzo et al. "Modification of standard ISHAGE methodology for CD34+ cells count on thawed Cord Blood Units: results from a multi-center Eurocord/Netcord study." Bone Marrow Transplantation, 50 (2015): 562.

S. Servais, E. BAUDOUX, B. Brichard, D. Bron, C. Debruyn, M. De Bruyère, D. De Hemptinne et al. "Circadian and circannual variations in cord blood hematopoietic cell composition." Haematologica, 100, no. 1 (January 2015): 32-34. doi:10.3324/haematol.2014.115394

R. SACCARDI, C. AZQUETA, L. BALLERINI, E. BAUDOUX, S. DAL POZZO, S. GOMEZ, G. KOGLER et al. "Flow Cytometry Assessment of CD34+ Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study." Blood, 124 (06 December 2014).

O. DETRY, F. JOURET, M. VANDERMEULEN, P. ERPICUM, L. Delens, C. GREGOIRE, A. BRIQUET et al. "Cellules stromales mésenchymateuses et transplantation d'organes." Revue Médicale de Liège, 69 (December 2014): 53-56.

A. RUGGERI, M. LABOPIN, M. P. SORMANI, G. SANZ, J. SANZ, F. VOLT, G. MICHEL et al. "Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen." Haematologica, 99 (September 2014): 1509-1515. doi:10.3324/haematol.2014.109280

CALMELS, F. Boulanger, E. BAUDOUX, V. Decot, A. Fawaz, C. Giraud, B. Hivert, L. Garderet, N. Milpied, and Yakoub-Agha. "Modalités de conservation et de destruction des produits cellulaires cryopréservés : recommandations de la SFGM-TC." Pathologie Biologie, 62, no. 3 (01 July 2014). doi:10.1016/j.patbio.2014.05.006

J. De Vos, B. Birebent, C. Faucher, O. GIET, Y. Hicheri, C. Lemarie, E. BAUDOUX et al. "Contrôle de qualité des USP via segments attachés : recommandations de la SFGM-TC." Pathologie Biologie (2014). doi:10.1016/j.patbio.2014.05.005

M. Hannon, C. LECHANTEUR, S. Lucas, J. Somja, L. Seidel, L. Belle, F. Bruck et al. "Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease." Transfusion, 54, February (17 June 2014): 353-363. doi:10.1111/trf.12279

F. Baron, S. Humblet-Baron, G. Ehx, S. SERVAIS, M. HANNON, L. Belle, C. LECHANTEUR et al. "Thinking out of the box - New approaches to controlling GVHD." Current Hematologic Malignancy Reports, 9 (2014): 73-84. doi:10.1007/s11899-013-0187-9

C. LECHANTEUR, S. Baila, M. E. Janssen, O. GIET, A. BRIQUET, E. BAUDOUX, and Y. Beguin. "Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks." Journal of Stem Cell Research and Therapy, 4, no. 8 (2014): 1000222. doi:10.4172/2157- 7633.1000222

C. MOERMANS, C. LECHANTEUR, E. BAUDOUX, O. GIET, M. HENKET, L. SEIDEL, M. LEJEUNE et al. "Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning." Transplantation, 98, no. 3 (2014): 348-353. doi:10.1097/TP.0000000000000068

J. Klykens, J. Pirnay, G. Verbeken, O. GIET, E. BAUDOUX, R. Jashari, A. Vanderkelen, and N. Ectors. "Cleanrooms and tissue banking how happy I could be with either GMP or GTP?." Cell and Tissue Banking (2013). doi:10.1007/s10561-012-9355-8

V. Rocha, S. Spellman, M. Zhang, A. Ruggeri, D. Purtill, C. Brady, L. Baxter-Lowe et al. "Effect of HLA-matching recipients to donor non-inherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy." Biology of Blood and Marrow Transplantation (2012).

J. PIRNAY, N. ECTORS, C. DELLOYE, D. DUFRANE, E. BAUDOUX, M. VAN BRUSSEL, M. CASAER et al. "Beware of the commercialization of human cells and tissues: situation in the European Union." Cell and Tissue Banking (2012). doi:10.1007/s10561-012-9323-3

E. GLUCKMAN, V. ROCHA, E. BAUDOUX, M. BOO, J. KURTZBERG, K. WELTE, C. NAVARRETE, and S. VAN WALRAVEN. "Family-directed umbilical cord blood banking." Haematologica, 96, no. 11 (12 July 2011): 1700-17007. doi:10.3324/haematol.2011.047050

F. Baron, C. Lechanteur, E. Willems, F. Bruck, E. Baudoux, L. Seidel, J.-F. Vanbellinghen et al. "Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning." Biology of Blood and Marrow Transplantation, 16, no. 6 (2010): 838-47. doi:10.1016/j.bbmt.2010.01.011

E. Willems* , F. Baron* , E. Baudoux, N. Wanten, L. Seidel, J.-F. Vanbellinghen, C. Herens et al. "Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial." Leukemia, 23, no. 3 (2009): 608-10. doi:10.1038/leu.2008.248
* These authors have contributed equally to this work.

A. Brand, P. Rebulla, C. P. Engelfriet, H. W. Reesink, Y. Beguin, E. Baudoux, G. Kögler et al. "Cord blood banking." Vox Sanguinis, 95 (2008): 335-348. doi:10.1111/j.1423-0410.2008.01106.x

C. Bovy, E. Baudoux, J. Salmon, and Y. Beguin. "Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy." Transfusion, 46, no. 9 (2006): 1616-23. doi:10.1111/j.1537-2995.2006.00945.x

F. Baron, S. Copizza, E. Baudoux, G. Jerusalem, G. Fillet, and Y. Beguin. "CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer." Haematologica, 89, no. 9 (2004): 1146-8.

M. Andre, E. Baudoux, D. Bron, J.-L. Canon, V. D'Hondt, M.-F. Fassotte, L. D'Hondt et al. "Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies." Transfusion, 43, no. 1 (2003): 50-7. doi:10.1046/j.1537-2995.2003.00273.x

F. Baron, E. Baudoux, P. Frere, S. Tourqui, N. Schaaf-Lafontaine, C. Herens, B. De Prijck, G. Fillet, and Y. Beguin. "Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC." Bone Marrow Transplantation, 32, no. 8 (2003): 829-34. doi:10.1038/sj.bmt.1704220

F. Baron, P. Frere, E. Baudoux, B. Sautois, G. Fillet, and Y. Beguin. "Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma." Haematologica, 88, no. 4 (2003): 478-80.

F. Baron, P. Frere, E. Baudoux, N. Schaaf-Lafontaine, G. Fillet, and Y. Beguin. "Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update." Haematologica, 88, no. 7 (2003): 835-7.

F. Baron, N. Schaaf-Lafontaine, S. Humblet-Baron, N. Meuris, E. Castermans, E. Baudoux, P. Frere, V. Bours, G. Fillet, and Y. Beguin. "T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation." Transplantation, 76, no. 12 (2003): 1705-13. doi:10.1097/01.TP.0000093987.11389.F7

F. Baron, E. Baudoux, G. Fillet, and Y. Beguin. "Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation." Hematology, 7, no. 3 (2002): 137-43. doi:10.1080/1024533021000008173

F. Baron, E. Baudoux, P. Frere, S. Tourqui, N. Schaaf-Lafontaine, R. Greimers, C. Herens, G. Fillet, and Y. Beguin. "Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells." Journal of Hematotherapy and Stem Cell Research, 11, no. 2 (2002): 301-14. doi:10.1089/152581602753658484

F. Baron, B. Sautois, E. Baudoux, G. Matus, G. Fillet, and Y. Beguin. "Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation." Experimental Hematology, 30, no. 6 (2002): 546-54. doi:10.1016/S0301-472X(02)00795-6

F. Baron, J. Siquet, N. Schaaf-Lafontaine, E. Baudoux, J.-P. Hermanne, G. Fillet, and Y. Beguin. "Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation." Haematologica, 87, no. 1 (2002): 78-88.

C. P. Engelfriet, H. W. Reesink, J. E. Wagner, G. Kogler, V. Rocha, P. Wernet, L. Lecchi et al. "International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation." Vox Sanguinis, 83, no. 2 (2002): 172-87. doi:10.1046/j.1423-0410.2002.00197.x

B. Sautois, E. Baudoux, J. Salmon, S. Michaux, N. Schaaf-Lafontaine, M. Pereira-Martins, J.-M. Paulus, G. Fillet, and Y. Beguin. "Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation." Haematologica, 86, no. 11 (2001): 1209-18.

E. Baudoux, F. Blaffart, C. Bouffioux, M. Caprasse, F. Courtois, M.-R. Cremasco, E. De Pasqual et al. "La commission d'hemovigilance du CHU." Revue Médicale de Liège, 55, no. 9 (2000): 878-80.

V. Fraipont, B. Sautois, E. Baudoux, M. Pereira-Martins, M.-F. Fassotte, J. P. Hermanne, G. Jerusalem et al. "Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF." Transfusion, 40, no. 3 (2000): 339-47. doi:10.1046/j.1537-2995.2000.40030339.x

J. Salmon, S. Michaux, J. P. Hermanne, E. Baudoux, C. Gerard, D. Sondag, G. Fillet, and Y. Beguin. "Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation." Transfusion, 39, no. 8 (1999): 824-7. doi:10.1046/j.1537-2995.1999.39080824.x

B. Sautois, V. Fraipont, E. Baudoux, M.-F. Fassotte, J. P. Hermanne, G. Jerusalem, V. Bours et al. "Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields." Haematologica, 84, no. 4 (1999): 342-9.

E. Baudoux, U. Margraff, A. Coenen, X. Jacobs, M. Deboutez, C. Lungu, and D. Sondag-Thull. "Hemovigilance: Clinical Tolerance of Solvent-Detergent Treated Plasma." Vox Sanguinis, 74, Suppl 1 (1998): 237-9. doi:10.1111/j.1423-0410.1998.tb05479.x

Y. Beguin, E. Baudoux, B. Sautois, V. Fraipont, N. Schaaf-Lafontaine, M. Pereira-Martins, J.-M. Paulus, D. Sondag, and G. Fillet. "Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells." Transfusion, 38, no. 2 (1998): 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x

M. Jacquet, V. LAMBERT, E. BAUDOUX, M. Muller, P. Kremers, and J. Gielen. "Correlation between P450 CYP1A1 Indelibility, MsPI Genotype and Lung Cancer Incidence." European Journal of Cancer, 32A, no. 10 (April 1996): 1701-1706.

Scientific congresses and symposiums

Published communications

H. Rafii, C. Kenzey, F. Volt, J. Sanz, G. Michel, J. H. Dalle, K. Kleinschmidt et al. "Optimizing Outcomes of Acute Leukemia After Transplants with Single Unrelated Cord Blood Units Selected According to Current International Recommendations for Cell Dose and HLA Match." Bone Marrow Transplantation, 55, no. 4 (11 December 2020): 170-171.

O. DETRY, M. VANDERMEULEN, M.-H. DELBOUILLE, J. SOMJA, N. BLETARD, A. BRIQUET, C. LECHANTEUR et al. "UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE." Transplant International, 30, suppl 1 (January 2017): 8 (O12.

J.-P. HAUZEUR, M. Tungouz, C. LECHANTEUR, Y. Beguin, E. BAUDOUX, V. de maertelaer, S. Pather et al. "Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée." Revue de Chirurgie Orthopédique et Traumatologie, 102 (October 2016): 73. doi:10.1016/j.rcot.2016.08.002

L. WEEKERS, P. Erpicum, O. DETRY, C. BONVOISIN, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up." Transplant International, 29, Suppl 2 (2016): 13 -p6.

L. WEEKERS, P. ERPICUM, O. DETRY, F. JOURET, C. LECHANTEUR, M.-H. DELBOUILLE, A. BRIQUET, E. BAUDOUX, and Y. BEGUIN. "Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis." Transplant International, 28, S4 (November 2015): 223-224/BO278.

L. WEEKERS, P. ERPICUM, O. DETRY, C. LECHANTEUR, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis." American Journal of Transplantation, 15, suppl 3 (May 2015).

E. BAUDOUX. "Cord blood banking Introduction-State of the art." In World Cord blood congress IV and innovative therapies for sickle cell diseaseedited by E. Gluckman and Cavazzana. 2013.

R. SACCARDI, L. Tucunduva, A. Ruggeri, I. Ionescu, G. Koegler, S. Querol, L. Lecchi et al. "Effect of volume reduction of cord blood units before storage on transplantation outcomes: a retrospective analysis of Eurocord-EBMT and Netcord." Bone Marrow Transplantation, 48 (01 April 2013): 34.

E. WILLEMS, E. CASTERMANS, F. Baron, E. BAUDOUX, N. Wanten, C. Bonnet, K. HAFRAOUI, P. Frère, G. Fillet, and Y. Beguin. "Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial." Blood, 106 (1075) (2005).

Oral communications or posters

S. VIEUJEAN, J.-P. LOLY, L. BOUTAFFALA, P. MEUNIER, C. REENAERS, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, Y. BEGUIN, and E. LOUIS. "Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study." Poster session presented at United European Gastroenterology, October 2021.

L. WEEKERS, P. ERPICUM, O. DETRY, C. BONVOISIN, M.-H. DELBOUILLE, C. LECHANTEUR, A. BRIQUET, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up." Paper presented at 24th Annual Meeting, Bruxelles, Belgium, 16 March 2017.

E. BAUDOUX. "Sang de cordon état des lieux et perspectives." Paper presented at Congrès commun SFGM-TC 16e CONGRES et de la SFBCT 8e CONGRES, Liège, Belgium, 16 November 2016.

P. Erpicum, L. WEEKERS, O. DETRY, C. BONVOISIN, C. LECHANTEUR, A. BRIQUET, E. BAUDOUX, F. JOURET, and Y. BEGUIN. "Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up." Paper presented at Annual Meeting of the BVN-SBN, Bruxelles, Belgium, 28 April 2016.

C. Grégoire, Y. Beguin, M. Hannon, S. DUBOIS, E. BAUDOUX, A. BRIQUET, C. LECHANTEUR, G. Ehx, and F. Baron. "Umbilical cord mesenchymal stromal cells are superior to bone marrow and adipose tissue-derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host disease in mice." Poster session presented at 31th General Meeting of the Belgian Hematological Society, 29 January 2016.

E. BAUDOUX, C. Lefebvre, and A. FASTH. "CORD DONOR Safety." Paper presented at International Donor Registry Conference 2014, London, United Kingdom, 16 May 2014.

O. DETRY, M.-H. DELBOUILLE, C. LECHANTEUR, J. SOMJA, A. DE ROOVER, L. WEEKERS, J.-P. SQUIFFLET et al. "INFUSION OF THIRD-PARTY MESENCHYMAL STEM CELLS (MSC) AFTER KIDNEY AND LIVER TRANSPLANTATION: A PHASE I-II, OPEN-LABEL, CLINICAL STUDY (EudraCT 2011-001822-81 & NCT01429038)." Poster session presented at 13eme rencontre de Beaune, Beaune, France, 30 May 2013.

O. DETRY, M.-H. DELBOUILLE, C. LECHANTEUR, J. SOMJA, A. DE ROOVER, L. WEEKERS, P. DELVENNE, E. BAUDOUX, and Y. BEGUIN. "Infusion of third party mesenchymal stem cells (MSC) after kidney and liver transplantation: a phase I-II, open-label, clinical study." Paper presented at 4th Expert meeting, Barcelona, Spain, 19 October 2012.

F. Baron, E. WILLEMS, C. LECHANTEUR, E. BAUDOUX, P. Frere, J. Vanbellinghen, F. Bruck et al. "Co-transplantation of mesenchymal stem cells might mitigate acute GvHD without abrogating graftversus- tumour alloreactivity after allogeneic transplantation with non-myeloablative conditioning." Paper presented at 35th EBMT Annual Meeting, 2009.

E. WILLEMS, E. CASTERMANS, F. Baron, E. BAUDOUX, N. Wanten, C. Bonnet, K. HAFRAOUI, P. Frère, G. Fillet, and Y. Beguin. "Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial." Paper presented at 21st General Meeting of the Belgian Hematological Society, 2006.

Book chapters and contributions to collective works

C. GREGOIRE, O. DETRY, F. Jouret, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, Y. Beguin, and O. GIET. "The use of mesenchymal stromal cells in solid organ transplantation." In The Biology and Therapeutic Application of Mesenchymal Cells, 825-835. Hoboken, United States: John Willey & Sons, Inc, 2017.

C. GREGOIRE, E. Louis, A. BRIQUET, C. LECHANTEUR, E. BAUDOUX, O. GIET, Y. Beguin, and F. BARON. "The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease." In The Biology and Therapeutic Application of Mesenchymal Cells, 730-753. Hoboken, United States: John Wiley & Sons, Inc, 2017.

J. Van Beckhoven, E. BAUDOUX, M. Duffy, H. Elmoazzen, N. Elwood, E. Gluckman, S. Gomez et al. "Cord Blood Banking: Cord blood management and evaluation: International networking." In A gift for life, WMDA handbook for blood stem cell donationedited by W. Hwang, M. Boo, and T. Bart, 178-180. WMDA, 2013.

E. Baudoux, M. Janssens, Y. Beguin, D. Sondag, G. Fillet, and M. Lamy. "Erythropoietin in surgery." In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion, 213-217. 1993.

Expert reports

E. BAUDOUX, Y. BEGUIN, Y. Benoit, J. Billiet, A. Delforge, T. DEVOS, D. Latinne et al. "Cord blood for allogeneic use: Clinical and scientific aspects?." 8784. Bruxelles, Belgium: Conseil Supérieur de la Santé, 2012.

E. Angenon, E. BAUDOUX, Y. BEGUIN, Y. benoit, J. Billiet, A. Delforge, T. Devos et al. "Autologous cord blood use: Clinical and scientific aspects." 8677. 2011.

Learning materials

Others

E. BAUDOUX, O. GIET, M. Jöris, C. Byam, V. Rocha, I. Ionescu, and H. Elmoazzen. "Importing and Exporting Cord Blood Units." Foundation for the Accreditation of Cellular Therapies. 2016.

E. BAUDOUX. "Donor and stem cell source selection." Belgian Hematological Society, Donor and stem cell source selection. 2012.

Other publications and communications

Articles in scientific journals without peer reviewing

C. Reenaers, R. Gillard, C. Coimbra, R. Gillard, P. Meunier, C. Lechanteur, E. BAUDOUX, L. Boutaffala, Y. Beguin, and E. Louis. "Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study." Journal of Crohn's and Colitis (In press).

C. GREGOIRE, S. SERVAIS, E. WILLEMS, E. BAUDOUX, C. LECHANTEUR, A. BRIQUET, V. Bettonville et al. "Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives." Revue Médicale de Liège, 77, no. 4 (April 2022): 206-211.

E. Baudoux. "Autologous Blood Donation Plus Epoetin Alfa in Nonanemic Orthopedic Surgery Patients." Seminars in Hematology, 33, 2 Suppl 2 (April 1996): 31-2, discussion 33.